Milwidsky A, Gal A, Mayer M
Gynecol Obstet Invest. 1984;18(5):230-3. doi: 10.1159/000299086.
The potential involvement of intracellular proteases in the pathophysiology of fibromyoma was studied by assay of activity of two proteolytic enzymes in fibromyoma and adjacent normal myometrium. Protease I, a soluble acid protease and protease II, a particulate protease optimally active at the neutral pH range are present in fibromyoma as well as in normal myometrial tissue. No consistent difference was observed between the specific activities of these enzymes in the fibromyoma and the surrounding myometrium. The large variation in the specific activity of the protease noted among normal and fibroid tissue samples from different patients cannot be ascribed to differences in cellularity. This variance might suggest differences in rate of processing of steroid hormones or different degrees of vascularization. The present findings do not support a major role for modulation of intracellular protease activities in the development of fibromyoma.
通过检测纤维瘤和相邻正常子宫肌层中两种蛋白水解酶的活性,研究了细胞内蛋白酶在纤维瘤病理生理学中的潜在作用。蛋白酶I是一种可溶性酸性蛋白酶,蛋白酶II是一种在中性pH范围内活性最佳的颗粒性蛋白酶,它们在纤维瘤以及正常子宫肌层组织中均有存在。在纤维瘤和周围子宫肌层中,未观察到这些酶的比活性存在一致差异。不同患者的正常组织和纤维瘤组织样本中蛋白酶比活性的巨大差异不能归因于细胞数量的差异。这种差异可能表明类固醇激素加工速率的差异或血管化程度的不同。目前的研究结果不支持细胞内蛋白酶活性调节在纤维瘤发生发展中起主要作用。